IPP Bureau

Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development
Shilpa Biologicals' PartnerPower promises real-time transparency in biologics development

By IPP Bureau - June 23, 2026

New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making

KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru
KIMS Hospitals launches RENOVA Oncology Institute in Bengaluru

By IPP Bureau - June 23, 2026

KIMS RENOVA Oncology Institute, in association with the Samrohana Cancer Foundation, announced the “134 Free Screening Camp Pledge”,

Teva submits FDA application for experimental Tourette syndrome treatment ecopipam
Teva submits FDA application for experimental Tourette syndrome treatment ecopipam

By IPP Bureau - June 23, 2026

The filing is backed by positive Phase 3 results recently published in JAMA Neurology

FDA advisory panel backs Moderna flu vaccine candidate for older adults
FDA advisory panel backs Moderna flu vaccine candidate for older adults

By IPP Bureau - June 23, 2026

The backing comes as influenza remains a persistent public health burden

FDA clears 131 drugs as global pharma approval momentum rebounds in 2025
FDA clears 131 drugs as global pharma approval momentum rebounds in 2025

By IPP Bureau - June 23, 2026

After a volatile decade in which approvals swung sharply from year to year, 2025’s total pushed past long-term norms, exceeding the 10-year average

Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results
Roche’s Lunsumio VELO–Polivy combo moves closer to FDA decision after strong lymphoma trial results

By IPP Bureau - June 23, 2026

The safety profile of the Lunsumio and Polivy combination was consistent with the known profiles of the individual study medicines

WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center
WuXi Biologics wins fourth EMA certification for Suzhou Biosafety Center

By IPP Bureau - June 23, 2026

Clearing 19 biologics for Europe market

ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward
ZEISS and Envision Health Technologies team up to push VR-based glaucoma testing forward

By IPP Bureau - June 23, 2026

The move comes as demand rises for wider access to glaucoma screening and more flexible clinical workflows

HCG launches breast Cancer Care Clinic in Bengaluru
HCG launches breast Cancer Care Clinic in Bengaluru

By IPP Bureau - June 23, 2026

About 250+ women riders participate in the awareness ride where free breast screening camp were conducted

Parexel biotech incubator to connect early-stage innovation with clinical development expertise
Parexel biotech incubator to connect early-stage innovation with clinical development expertise

By IPP Bureau - June 23, 2026

The incubator anchored at the company's global headquarters in Raleighla launches alongside an inaugural partnership with Cape Fear BioCapital, a Durham-based seed-stage venture capital firm

Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit
Lonza reports CHF 3.03 billion in sales amid divestment of Capsules & Health Ingredients unit

By IPP Bureau - June 23, 2026

As per the company’s Restated H1 2025 Financials, its continuing business delivered CORE EBITDA of CHF 922 million, representing a margin of 30.4%

QMS Medical targets Rs. 500 crore revenue by FY29
QMS Medical targets Rs. 500 crore revenue by FY29

By IPP Bureau - June 23, 2026

The company reported consolidated revenue of Rs. 172.9 crore and EBITDA of Rs 25.9 crore in FY26

India achieves landmark milestone of 5 lakh organ donation pledges
India achieves landmark milestone of 5 lakh organ donation pledges

By IPP Bureau - June 23, 2026

As per union government, growing public participation reflects rising awareness and collective commitment towards advancing organ and tissue donation

KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute
KIMS Hospitals Bengaluru launches KIMS RENOVA Oncology Institute

By IPP Bureau - June 23, 2026

Advanced comprehensive oncology centre was inaugurated by the legendary former Indian cricketer VVS Laxman

BioMed X and Biogen launch global neuroimmunology research challenge
BioMed X and Biogen launch global neuroimmunology research challenge

By IPP Bureau - June 23, 2026

Initiative seeks innovative experimental and computational approaches to uncover neural circuits regulating immune function and identify novel therapeutic targets

Latest Stories

Interviews

Packaging